Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Ebiomedicine|October 24, 2025
Unravelling tandem repeat-mediated mutagenesis drive rapid diversification of KPC enzymes: emergence of blaKPC-263 and enhanced resistance to ceftazidime-avibactamHaowei Ye, Ruishan Liu, Jie Shen, et al.
Current Medical Research and Opinion|July 24, 2025
Real-world effectiveness of single-inhaler fluticasone furoate/umeclidinium bromide/vilanterol in Chinese patients with symptomatic chronic obstructive pulmonary disease (COPD): a post-marketing, prospective, multicenter, observational studyJinfang Ma, Fangfang Dou, Wutie Zhou, et al.
Microbiology Spectrum|July 23, 2024
Emergence of plasmid-borne tet(X4) resistance gene in clinical isolate of eravacycline- and omadacycline-resistant Klebsiella pneumoniae ST485Xiaojing Liu, Yi Liu, Xiaohan Ma, et al.
International Journal of Biological Macromolecules|August 27, 2025
De novo design mini-binder proteins targeting the capsid-forming domain of type 2 PRRSV nucleocapsid protein to inhibit PRRSV replication in vitroZhang Liu, Ke Ming, Banbin Xing, et al.
Cancer Science|June 27, 2024
Outcomes in non-small cell lung cancer with uncommon epidermal growth factor receptor L858 substitutions under first-line epidermal growth factor receptor tyrosine kinase inhibitors: A large real-world cohort studyYouyou Shao, Jingying Zhang, Zhi Feng, et al.
Trials|June 5, 2026
Effectiveness of digital inhaled therapy management and respiratory muscle training in moderate to severe COPD patients: study protocol for a randomized controlled, assessor-blinded, multicenter trialYiqing Xu, Mengyun Zhou, Xiaoli Hu, et al.
Cell Reports. Medicine|June 12, 2026
Toward generalizable prediction of cancer signal using a cell-free DNA language modelYang Xu, Hua Bao, Daxin Huang, et al.
ACS Omega|February 10, 2025
Design of the Inhibitors for Pseudorabies Virus Replication by Reinforcement Learning from HSV-1 DNA Polymerase InhibitorsLin Wei, Yang Hu, Licheng Bai, et al.
European Journal of Medicinal Chemistry|March 14, 2025
Rapid discovery of pseudorabies virus inhibitors repurposed from the antimicrobial agent ciprofloxacinLin Wei, Yun You, Yang Hu, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2025
Phylogenetic diversification and fitness trade-offs of TetA variants in mediating eravacycline resistance in Klebsiella pneumoniaeMeimei Fan, Zhixun Zhang, Xiaowei Liu, et al.
Pageof 7